Concord Biotech

543960 · ISIN INE338H01029 · 2 filings, FY 2024-25 to FY 2025-26 · standalone basis

Reclaimed at end of life

Tonnes as filed. Totals combine re-used, recycled and safely disposed, because filers place comparable activity in different columns.

CategoryFY 2024-25FY 2025-26
Plastics including packaging 11.9not filed
E-waste 0.16not filed
Hazardous waste 3,045.23not filed
Other waste 602.23not filed
Total reclaimed 3,659.520

NIC codes filed

Products and services accounting for 90 percent of turnover, latest filing.

CodeDescription as filedShare of turnover
210 Manufacturing of Pharmaceuticals, medicinal chemical and botanical products. 78.60%
210 Formulations 21.40%

Source filings

YearBasisTaxonomyTurnover as filed
FY 2024-25 Standalone 2025-05-31 12,00,08,69,000
FY 2025-26 Standalone 2026-02-28 10,55,07,09,892

Figures read from BRSR XBRL as filed. Nothing estimated or restated. How this works · Report an error